Low disease activity state in juvenile-onset systemic lupus erythematosus.
Kübra OztürkŞengül ÇağlayanAyşe TanatarEsra BaglanGülçin Otar YenerGülşah Kavrul KayaalpSerife Gül KaradagFerhat DemirHafize Emine SönmezSemanur OzdelMustafa CakanNuray Aktay AyazBetul Sozerinull nullPublished in: Lupus (2021)
Targeting LLDAS in jSLE, even with long-term, low-dose corticosteroid use, seems to be an achievable goal in clinical practice.